Ibufetum (Ibuprofen)

• Ibufetum, a topical NSAID, is used to manage conditions that involve localized pain and inflammation.
• Local pain relief: provides symptomatic relief of minor aches and pains on the skin surface.
• Musculoskeletal discomfort: eases soreness in muscles, tendons and joints caused by overuse or strain.
• Inflammation reduction: diminishes swelling and redness associated with minor soft‑tissue injuries.

• Ibuprofen inhibits cyclooxygenase‑1 and cyclooxygenase‑2 enzymes in peripheral tissues, which blocks the conversion of arachidonic acid to prostaglandins. The reduced prostaglandin synthesis lowers the inflammatory response and nociceptive signaling, resulting in decreased pain and swelling at the site of topical application.

Topical ibuprofen can cause skin‑related reactions and, rarely, systemic adverse events.

Common Side Effects

• Skin irritation or mild redness at the application site.
• Itching or a burning sensation after use.
• Dryness or peeling of the treated skin.
• Localized swelling that resolves quickly.
• Mild rash confined to the area of contact.

Serious or Rare Side Effects

• Allergic reactions such as angioedema or urticaria.
• Severe cutaneous adverse reactions (e.g., Stevens‑Johnson syndrome).
• Systemic gastrointestinal ulceration or bleeding.
• Renal impairment, especially with prolonged use.
• Hepatic dysfunction or elevated liver enzymes.
• Cardiovascular events such as hypertension or thrombotic episodes.

• When using Ibufetum, observe the following safety measures.
• Avoid use on broken or infected skin: apply only to intact epidermis.
• Do not combine with other topical NSAIDs: concurrent use may increase irritation.
• Limit application area: do not exceed the recommended surface area per dose.
• Consult a healthcare professional if you are on systemic anticoagulants or have kidney disease.
• Keep away from eyes, mucous membranes and the genital region.
• Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Ibufetum may interact with systemic medications and other topical agents.

Major Interactions (Avoid)

• Oral anticoagulants (e.g., warfarin): increased bleeding risk.
• Systemic NSAIDs: additive gastrointestinal toxicity.
• ACE inhibitors or ARBs: potential renal function decline.
• Lithium therapy: elevated lithium serum levels.
• Methotrexate: enhanced toxicity.

Moderate Interactions (Monitor Closely)

• Diuretics: monitor renal parameters.
• Corticosteroid creams: heightened skin atrophy risk.
• Antihypertensive drugs: possible reduction in efficacy.
• Selective serotonin reuptake inhibitors: increased bleeding tendency.
• Alcohol consumption: may exacerbate gastrointestinal irritation.